European Union has voted to continue funding embryonic stem cell research after a heated debate at the European Parliament on Tuesday.

IBM offers a few details of its new consultancy service for R&D management. Pity about the jargon.

A team of researchers from ETH-Zürich is looking for investment for their spin-off company, XpresSys, to commercialise novel protein expression technology. The technology has the potential to revolutionise screening process for new drugs.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.

Cuts in federal funding have forced UC Berkeley's RAD Lab to seek industry funding. But the money may not be enough to plug the gap.

USA Today reports declining R&D budgets in the USA, albeit in, it seems, just one tech sector.

The future of European Union funded embryonic stem cell research hangs in the balance after a heated debate at the European Parliament on Tuesday.

It may have started from a low base, but the Indian biotech industry is hurtling past the global growth rate. And overseas companies are anxious to get in on the action.

For a bunch of IT experts, the EU's IST World has come up with a baffling web site, especially when the idea is to make life easy for beginners.

Indian firms are training large numbers of patent agents - with their eye on the large number of companies abroad looking for cheaper patenting.